CNS insider now holds 528,903 shares after RSU dividend credits

Rhea-AI Filing Summary

Cohen & Steers, Inc. (CNS) reported a routine insider equity award for its Chief Operating Officer and Executive Vice President on a Form 4. On 11/20/2025, the officer acquired 227 shares of common stock at a price of $0. These shares are described as dividend equivalent restricted stock units that accrued on earlier unvested restricted stock unit grants from January 2022, January 2023, January 2024 and January 2025 in connection with the company’s fourth quarter 2025 dividend. After this transaction, the officer beneficially owns 528,903 shares of Cohen & Steers common stock, held directly. This filing reflects compensation-related accruals rather than an open-market purchase or sale.

Insider Trade Summary

Net Buyer: 227 shares

Net Buy 1 txn

Insider DERECHIN ADAM M

Role Chief Operating Officer, EVP

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	227	$0.00	$0.00

Holdings After Transaction: Common Stock — 528,903 shares (Direct)

Footnotes (1)

1. F1. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's fourth quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/20/2025 - 05:51 PM Learn about SEC filing dates

FAQ

What did the Cohen & Steers (CNS) Form 4 filed on 11/20/2025 report?

The Form 4 reports that a Cohen & Steers Chief Operating Officer and Executive Vice President acquired 227 shares of common stock on 11/20/2025 through dividend equivalent restricted stock units.

How many Cohen & Steers (CNS) shares does the insider own after this Form 4 transaction?

Following the reported transaction, the officer beneficially owns 528,903 shares of Cohen & Steers common stock in direct ownership.

What is the nature of the 227 CNS shares reported in this Form 4?

The 227 shares represent dividend equivalent restricted stock units tied to the issuer's fourth quarter 2025 dividend, credited on unvested restricted stock units granted in January 2022, 2023, 2024 and 2025.

Was there a cash purchase involved in the 227 CNS shares reported?

No cash purchase is shown; the 227 shares were acquired at a price of $0 as dividend equivalent restricted stock units rather than through an open-market buy.

Does the Cohen & Steers (CNS) Form 4 report any derivative security transactions?

The section for derivative securities is present but does not list any specific derivative security transactions in the excerpt provided.

What role does the reporting person hold at Cohen & Steers (CNS)?

The reporting person is identified as an officer of Cohen & Steers, serving as Chief Operating Officer and Executive Vice President.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DERECHIN ADAM M

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer, EVP

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		A		227(1)	A	$0	528,903	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's fourth quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.